SOBI INJ
Sodium Bicarbonate IP 8.4%
WHO-GMP
ISO Certified
DCGI Approved
Antacid/Anti-Ulcer/Anti-Coagulant
SOBI INJ
SOBI INJ (Sodium Bicarbonate IP 8.4%) — Injection from NYX Pharmaceuticals' WHO-GMP certified Antacid/Anti-Ulcer/Anti-Coagulant range.
- Composition
- Sodium Bicarbonate IP 8.4%
- Dosage Form
- Injection
- Packing
- 5X25ML, TRAY+AMPOULE
- Therapy Class
- Antacid/Anti-Ulcer/Anti-Coagulant
- Category
- Antacid/Anti-Ulcer/Anti-Coagulant
For use by registered medical practitioners, hospitals and licensed distributors only. Batch-wise Certificate of Analysis shared with every dispatch.
Ready to Start Your Own Pharma Business?
Join 800+ successful franchise partners. Get monopoly rights, WHO-GMP certified products and complete marketing support.